Both in Pharmaceuticals
Karyopharm Therapeutics vs PMGC Holdings
Over the past year KPTI returned −98.7% and ELAB returned −99.9%; their daily moves had a correlation of 0.01.
KPTI −98.7% ELAB −99.9%Growth of $1, one year, split-adjusted
| Metric | KPTI | ELAB |
|---|---|---|
| Price | $0.0729 | $1.92 |
| Market cap | $1.7M | $1.6M |
| Today | −17.44% | −1.03% |
| 1 month | −88.8% | −41.3% |
| 6 months | −99.2% | −91.0% |
| Year to date | −99.0% | −99.5% |
| 1 year | −98.8% | −99.9% |
| Revenue growth (YoY) | −11.9% | — |
| Gross margin | 96.8% | 29.5% |
| Net margin | −200.5% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.0× | 0.6× |
| Net cash | -$184.8M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 413.8% | 677.7% |
| Short % of float | 34.2% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).